{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:30:24Z","timestamp":1794551424239,"version":"4.9.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>KIF1A<\/jats:italic>\n                    -Associated Neurological Disorder (KAND) is a rare, progressive neurodegenerative condition caused by variants in the\n                    <jats:italic>KIF1A<\/jats:italic>\n                    gene, which encodes a kinesin-3 motor protein essential for anterograde axonal transport of synaptic vesicles, dense core vesicles, and organelles in neurons. KAND comprises a broad spectrum of overlapping neurological phenotypes, including hereditary spastic paraplegia, intellectual disability, peripheral neuropathy, optic nerve atrophy, epilepsy, and progressive motor decline. Pathogenic variants in\n                    <jats:italic>KIF1A<\/jats:italic>\n                    disrupt the balance of intracellular transport and neuronal signalling through diverse mechanisms, manifesting with highly variable disease onset, severity, and clinical progression. Although advances in genomic testing have improved diagnosis, reported KAND cases remain concentrated in developed countries, highlighting ongoing global inequities in access to diagnosis and care. At present, no cure exists for KAND; treatment is limited to symptom management. A deeper understanding of KIF1A function, supported by the development of robust cellular and animal models, is critical for therapeutic development. This review summarises the clinical and molecular features of KAND and highlights current and emerging strategies aimed at slowing disease progression or correcting its underlying causes. We emphasise the urgent need for targeted treatment strategies addressing the heterogeneity of KAND.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01978-8","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:15:03Z","timestamp":1764267303000},"page":"1417-1431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["KIF1A-associated neurological disorders: therapeutic opportunities and challenges"],"prefix":"10.1038","volume":"34","author":[{"given":"Qing","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Verden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8431-0641","authenticated-orcid":false,"given":"John","family":"Christodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0689-2965","authenticated-orcid":false,"given":"Simranpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"1978_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/0092-8674(95)90538-3","volume":"81","author":"Y Okada","year":"1995","unstructured":"Okada Y, Yamazaki H, Sekine-Aizawa Y, Hirokawa N. The neuron-specific kinesin superfamily protein KIF1A is a unique monomeric motor for anterograde axonal transport of synaptic vesicle precursors. Cell. 1995;81:769\u201380.","journal-title":"Cell"},{"key":"1978_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1083\/jcb.201205070","volume":"198","author":"B Jenkins","year":"2012","unstructured":"Jenkins B, Decker H, Bentley M, Luisi J, Banker G. A novel split kinesin assay identifies motor proteins that interact with distinct vesicle populations. J Cell Biol. 2012;198:749\u201361.","journal-title":"J Cell Biol"},{"key":"1978_CR3","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1002\/humu.24079","volume":"41","author":"S Kaur","year":"2020","unstructured":"Kaur S, Van Bergen NJ, Verhey KJ, Nowell CJ, Budaitis B, Yue Y, et al. Expansion of the phenotypic spectrum of de novo missense variants in kinesin family member 1A (KIF1A). Hum Mutat. 2020;41:1761\u201374.","journal-title":"Hum Mutat"},{"key":"1978_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jocn.2018.10.091","volume":"61","author":"D Samanta","year":"2019","unstructured":"Samanta D, Gokden M. PEHO syndrome: KIF1A mutation and decreased activity of mitochondrial respiratory chain complex. J Clin Neurosci. 2019;61:298\u2013301.","journal-title":"J Clin Neurosci"},{"key":"1978_CR5","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2021108899","volume":"41","author":"M Morikawa","year":"2022","unstructured":"Morikawa M, Jerath NU, Ogawa T, Morikawa M, Tanaka Y, Shy ME, et al. A neuropathy-associated kinesin KIF1A mutation hyper-stabilizes the motor-neck interaction during the ATPase cycle. EMBO J. 2022;41:e108899.","journal-title":"EMBO J"},{"key":"1978_CR6","unstructured":"KIF1A.ORG. 2025. Available from: https:\/\/www.kif1a.org\/."},{"key":"1978_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41525-019-0101-z","volume":"4","author":"CL van Eyk","year":"2019","unstructured":"van Eyk CL, Corbett MA, Frank MSB, Webber DL, Newman M, Berry JG, et al. Targeted resequencing identifies genes with recurrent variation in cerebral palsy. NPJ Genom Med. 2019;4:27.","journal-title":"NPJ Genom Med"},{"key":"1978_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2024.101169","volume":"26","author":"KK Sudnawa","year":"2024","unstructured":"Sudnawa KK, Li W, Calamia S, Kanner CH, Bain JM, Abdelhakim AH, et al. Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder. Genet Med. 2024;26:101169.","journal-title":"Genet Med"},{"key":"1978_CR9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"J Lonsdale","year":"2013","unstructured":"Lonsdale J, Thomas J, Salvatore M, Phillips R, Lo E, Shad S, et al. The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013;45:580\u20135.","journal-title":"Nat Genet"},{"key":"1978_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1083\/jcb.141.2.431","volume":"141","author":"Y Yonekawa","year":"1998","unstructured":"Yonekawa Y, Harada A, Okada Y, Funakoshi T, Kanai Y, Takei Y, et al. Defect in synaptic vesicle precursor transport and neuronal cell death in KIF1A motor protein-deficient mice. J Cell Biol. 1998;141:431\u201341.","journal-title":"J Cell Biol"},{"key":"1978_CR11","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/nrm2807","volume":"10","author":"N Hirokawa","year":"2009","unstructured":"Hirokawa N, Nitta R, Okada Y. The mechanisms of kinesin motor motility: lessons from the monomeric motor KIF1A. Nat Rev Mol Cell Biol. 2009;10:877\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1978_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1073\/pnas.97.2.640","volume":"97","author":"Y Okada","year":"2000","unstructured":"Okada Y, Hirokawa N. Mechanism of the single-headed processivity: diffusional anchoring between the K-loop of kinesin and the C terminus of tubulin. Proc Natl Acad Sci USA. 2000;97:640\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1978_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1096621","volume":"305","author":"R Nitta","year":"2004","unstructured":"Nitta R, Kikkawa M, Okada Y, Hirokawa N. KIF1A alternately uses two loops to bind microtubules. Science. 2004;305:678\u201383.","journal-title":"Science"},{"key":"1978_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0960-9822(00)00316-X","volume":"10","author":"RB Case","year":"2000","unstructured":"Case RB, Rice S, Hart CL, Ly B, Vale RD. Role of the kinesin neck linker and catalytic core in microtubule-based motility. Curr Biol. 2000;10:157\u201360.","journal-title":"Curr Biol"},{"key":"1978_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000072","volume":"7","author":"JW Hammond","year":"2009","unstructured":"Hammond JW, Cai D, Blasius TL, Li Z, Jiang Y, Jih GT, et al. Mammalian Kinesin-3 motors are dimeric in vivo and move by processive motility upon release of autoinhibition. PLoS Biol. 2009;7:e72.","journal-title":"PLoS Biol"},{"key":"1978_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1399-3011.2005.00255.x","volume":"65","author":"DJ Rashid","year":"2005","unstructured":"Rashid DJ, Bononi J, Tripet BP, Hodges RS, Pierce DW. Monomeric and dimeric states exhibited by the kinesin-related motor protein KIF1A. J Pept Res. 2005;65:538\u201349.","journal-title":"J Pept Res"},{"key":"1978_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1083\/jcb.200308020","volume":"163","author":"J Al-Bassam","year":"2003","unstructured":"Al-Bassam J, Cui Y, Klopfenstein D, Carragher BO, Vale RD, Milligan RA. Distinct conformations of the kinesin Unc104 neck regulate a monomer to dimer motor transition. J Cell Biol. 2003;163:743\u201353.","journal-title":"J Cell Biol"},{"key":"1978_CR18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1534\/genetics.115.177337","volume":"201","author":"SL Edwards","year":"2015","unstructured":"Edwards SL, Yorks RM, Morrison LM, Hoover CM, Miller KG. Synapse-assembly proteins maintain synaptic vesicle cluster stability and regulate synaptic vesicle transport in Caenorhabditis elegans. Genetics. 2015;201:91\u2013116.","journal-title":"Genetics"},{"key":"1978_CR19","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1242\/jcs.056366","volume":"123","author":"X Xue","year":"2010","unstructured":"Xue X, Jaulin F, Espenel C, Kreitzer G. PH-domain-dependent selective transport of p75 by kinesin-3 family motors in non-polarized MDCK cells. J Cell Sci. 2010;123:1732\u201341.","journal-title":"J Cell Sci"},{"key":"1978_CR20","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0092-8674(02)00708-0","volume":"109","author":"DR Klopfenstein","year":"2002","unstructured":"Klopfenstein DR, Tomishige M, Stuurman N, Vale RD. Role of phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the Unc104 kinesin motor. Cell. 2002;109:347\u201358.","journal-title":"Cell"},{"key":"1978_CR21","doi-asserted-by":"publisher","first-page":"4143","DOI":"10.1242\/jcs.113.23.4143","volume":"23","author":"J Li","year":"2000","unstructured":"Li J, Lee GI, Van Doren SR, Walker JC. The FHA domain mediates phosphoprotein interactions. J Cell Sci. 2000;23:4143\u20139.","journal-title":"J Cell Sci"},{"key":"1978_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/1521654031000070636","volume":"55","author":"A Hammet","year":"2003","unstructured":"Hammet A, Pike BL, McNees CJ, Conlan LA, Tenis N, Heierhorst J. FHA domains as phospho-threonine binding modules in cell signaling. IUBMB Life. 2003;55:23\u20137.","journal-title":"IUBMB Life"},{"key":"1978_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.celrep.2018.06.071","volume":"24","author":"R Stucchi","year":"2018","unstructured":"Stucchi R, Pluci\u0144ska G, Hummel JJA, Zahavi EE, Guerra San Juan I, Klykov O, et al. Regulation of KIF1A-driven dense core vesicle transport: Ca(2+)\/CaM controls DCV Binding and Liprin-\u03b1\/TANC2 recruits DCVs to postsynaptic sites. Cell Rep. 2018;24:685\u2013700.","journal-title":"Cell Rep"},{"key":"1978_CR24","doi-asserted-by":"crossref","unstructured":"Boyle L, Rao L, Kaur S, Fan X, Mebane C, Hamm L, et al. Genotype and defects in microtubule-based motility correlate with clinical severity in KIF1A-associated neurological disorder. HGG Adv. 2021;2:100026.","DOI":"10.1016\/j.xhgg.2021.100026"},{"key":"1978_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.braindev.2021.11.007","volume":"44","author":"K Isobe","year":"2022","unstructured":"Isobe K, Ieda D, Miya F, Miyachi R, Otsuji S, Asai M, et al. Hemorrhagic shock and encephalopathy syndrome in a patient with a de novo heterozygous variant in KIF1A. Brain Dev. 2022;44:249\u201353.","journal-title":"Brain Dev"},{"key":"1978_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/humu.22709","volume":"36","author":"JR Lee","year":"2015","unstructured":"Lee JR, Srour M, Kim D, Hamdan FF, Lim SH, Brunel-Guitton C, et al. De novo mutations in the motor domain of KIF1A cause cognitive impairment, spastic paraparesis, axonal neuropathy, and cerebellar atrophy. Hum Mutat. 2015;36:69\u201378.","journal-title":"Hum Mutat"},{"key":"1978_CR27","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1007\/s00415-015-7899-9","volume":"262","author":"A Citterio","year":"2015","unstructured":"Citterio A, Arnoldi A, Panzeri E, Merlini L, D\u2019Angelo MG, Musumeci O, et al. Variants in KIF1A gene in dominant and sporadic forms of hereditary spastic paraparesis. J Neurol. 2015;262:2684\u201390.","journal-title":"J Neurol"},{"key":"1978_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41431-019-0497-z","volume":"28","author":"M Pennings","year":"2020","unstructured":"Pennings M, Schouten MI, Van Gaalen J, Meijer RPP, De Bot ST, Kriek M, et al. KIF1A variants are a frequent cause of autosomal dominant hereditary spastic paraplegia. Eur J Hum Genet. 2020;28:40\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1978_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40035-022-00320-2","volume":"11","author":"P Liao","year":"2022","unstructured":"Liao P, Yuan Y, Liu Z, Hou X, Li W, Wen J, et al. Association of variants in the KIF1A gene with amyotrophic lateral sclerosis. Transl Neurodegener. 2022;11:46.","journal-title":"Transl Neurodegener"},{"key":"1978_CR30","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ajhg.2011.06.013","volume":"89","author":"J-B Rivi\u00e8re","year":"2011","unstructured":"Rivi\u00e8re J-B, Ramalingam S, Lavastre V, Shekarabi M, Holbert S, Lafontaine J, et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet. 2011;89:219\u201330.","journal-title":"Am J Hum Genet"},{"key":"1978_CR31","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/ejhg.2016.42","volume":"24","author":"BP van de Warrenburg","year":"2016","unstructured":"van de Warrenburg BP, Schouten MI, de Bot ST, Vermeer S, Meijer R, Pennings M, et al. Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene-disease associations and unanticipated rare disorders. Eur J Hum Genet. 2016;24:1460\u20136.","journal-title":"Eur J Hum Genet"},{"key":"1978_CR32","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/ejhg.2014.297","volume":"23","author":"E Ylikallio","year":"2015","unstructured":"Ylikallio E, Kim D, Isohanni P, Auranen M, Kim E, L\u00f6nnqvist T, et al. Dominant transmission of de novo KIF1A motor domain variant underlying pure spastic paraplegia. Eur J Hum Genet. 2015;23:1427\u201330.","journal-title":"Eur J Hum Genet"},{"key":"1978_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12999-9","volume":"7","author":"CK Cheon","year":"2017","unstructured":"Cheon CK, Lim SH, Kim YM, Kim D, Lee NY, Yoon TS, et al. Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene. Sci Rep. 2017;7:12527.","journal-title":"Sci Rep"},{"key":"1978_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2113795119","volume":"119","author":"Y Anazawa","year":"2022","unstructured":"Anazawa Y, Kita T, Iguchi R, Hayashi K, Niwa S. De novo mutations in KIF1A-associated neuronal disorder (KAND) dominant-negatively inhibit motor activity and axonal transport of synaptic vesicle precursors. Proc Natl Acad Sci USA. 2022;119:e2113795119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1978_CR35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1101\/gr.117143.110","volume":"21","author":"Y Erlich","year":"2011","unstructured":"Erlich Y, Edvardson S, Hodges E, Zenvirt S, Thekkat P, Shaag A, et al. Exome sequencing and disease-network analysis of a single family implicate a mutation in KIF1A in hereditary spastic paraparesis. Genome Res. 2011;21:658\u201364.","journal-title":"Genome Res"},{"key":"1978_CR36","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/ejhg.2011.261","volume":"20","author":"S Klebe","year":"2012","unstructured":"Klebe S, Lossos A, Azzedine H, Mundwiller E, Sheffer R, Gaussen M, et al. KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet. 2012;20:645\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1978_CR37","doi-asserted-by":"publisher","unstructured":"Shewale DJ, Soppina P, Soppina V. KIF1A neurodegenerative disease mutations modulate motor motility and force generation. bioRxiv [Preprint]. 2023. Available from: https:\/\/doi.org\/10.1101\/2023.06.09.544228","DOI":"10.1101\/2023.06.09.544228"},{"key":"1978_CR38","doi-asserted-by":"publisher","first-page":"18429","DOI":"10.1073\/pnas.1905690116","volume":"116","author":"K Chiba","year":"2019","unstructured":"Chiba K, Takahashi H, Chen M, Obinata H, Arai S, Hashimoto K, et al. Disease-associated mutations hyperactivate KIF1A motility and anterograde axonal transport of synaptic vesicle precursors. Proc Natl Acad Sci USA. 2019;116:18429\u201334.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1978_CR39","doi-asserted-by":"crossref","unstructured":"Rao L, Li W, Shen Y, Chung WK, Gennerich A. Distinct clinical phenotypes in KIF1A-associated neurological disorders result from different amino acid substitutions at the same residue in KIF1A. Biomolecules. 2025;15:656.","DOI":"10.3390\/biom15050656"},{"key":"1978_CR40","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.neuron.2016.05.002","volume":"90","author":"Y Tanaka","year":"2016","unstructured":"Tanaka Y, Niwa S, Dong M, Farkhondeh A, Wang L, Zhou R, et al. The molecular motor KIF1A transports the TrkA neurotrophin receptor and is essential for sensory neuron survival and function. Neuron. 2016;90:1215\u201329.","journal-title":"Neuron"},{"key":"1978_CR41","doi-asserted-by":"crossref","unstructured":"Zhao M, Wang J, Liu M, Xu Y, Huang J, Zhang Y, et al. KIF1A, R1457Q, and P1688L mutations induce protein abnormal aggregation and autophagy impairment in iPSC-derived motor neurons. Biomedicines. 2024;12:1693.","DOI":"10.3390\/biomedicines12081693"},{"key":"1978_CR42","unstructured":"Education TCfG. Health conditions caused by changes in the KIF1A gene https:\/\/www.genetics.edu.au\/SitePages\/KIF1A.aspx: NSW Government; 2021 [updated November 2021]."},{"key":"1978_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1392858","volume":"15","author":"S Saini","year":"2024","unstructured":"Saini S, Tejani NH, Rayjade A. Striving for inclusivity: the crucial function of neurorehabilitation in the management of KIF1A syndrome. Front Neurol. 2024;15:1392858.","journal-title":"Front Neurol"},{"key":"1978_CR44","doi-asserted-by":"publisher","first-page":"972","DOI":"10.3390\/genes14050972","volume":"14","author":"J Paprocka","year":"2023","unstructured":"Paprocka J, Jezela-Stanek A, \u015amigiel R, Walczak A, Mierzewska H, Kutkowska-Ka\u017amierczak A, et al. Expanding the knowledge of KIF1A-dependent disorders to a group of polish patients. Genes. 2023;14:972.","journal-title":"Genes"},{"key":"1978_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63656","volume":"194","author":"A Kawashima","year":"2024","unstructured":"Kawashima A, Kodama K, Okubo Y, Endo W, Inui T, Ikeda M, et al. Long-term clinical observation of patients with heterozygous KIF1A variants. Am J Med Genet Part A. 2024;194:e63656.","journal-title":"Am J Med Genet Part A"},{"key":"1978_CR46","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41591-024-03197-y","volume":"30","author":"A Ziegler","year":"2024","unstructured":"Ziegler A, Carroll J, Bain JM, Sands TT, Fee RJ, Uher D, et al. Antisense oligonucleotide therapy in an individual with KIF1A-associated neurological disorder. Nat Med. 2024;30:2782\u20136.","journal-title":"Nat Med"},{"key":"1978_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s10048-021-00652-7","volume":"22","author":"CD van Karnebeek","year":"2021","unstructured":"van Karnebeek CD, Blydt-Hansen I, Matthews AM, Avramovic V, Price M, Drogemoller B, et al. Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects. neurogenetics. 2021;22:251\u201362.","journal-title":"neurogenetics"},{"key":"1978_CR48","doi-asserted-by":"crossref","unstructured":"Vitet H, Bruy\u00e8re J, Xu H, S\u00e9ris C, Brocard J, Abada YS, et al. Huntingtin recruits KIF1A to transport synaptic vesicle precursors along the mouse axon to support synaptic transmission and motor skill learning. eLife. 2023;12:e81011.","DOI":"10.7554\/eLife.81011"},{"key":"1978_CR49","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910889","volume":"12","author":"Y Ehinger","year":"2020","unstructured":"Ehinger Y, Bruy\u00e8re J, Panayotis N, Abada YS, Borloz E, Matagne V, et al. Huntingtin phosphorylation governs BDNF homeostasis and improves the phenotype of Mecp2 knockout mice. EMBO Mol Med. 2020;12:e10889.","journal-title":"EMBO Mol Med"},{"key":"1978_CR50","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E22-07-0276","volume":"33","author":"M Frank","year":"2022","unstructured":"Frank M, Nabb AT, Gilbert SP, Bentley M. Propofol attenuates kinesin-mediated axonal vesicle transport and fusion. Mol Biol Cell. 2022;33:ar119.","journal-title":"Mol Biol Cell"},{"key":"1978_CR51","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1074\/jbc.RA118.005765","volume":"294","author":"DV Lessard","year":"2019","unstructured":"Lessard DV, Zinder OJ, Hotta T, Verhey KJ, Ohi R, Berger CL. Polyglutamylation of tubulin\u2019s C-terminal tail controls pausing and motility of kinesin-3 family member KIF1A. J Biol Chem. 2019;294:6353\u201363.","journal-title":"J Biol Chem"},{"key":"1978_CR52","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.neuron.2017.11.018","volume":"96","author":"RP Tas","year":"2017","unstructured":"Tas RP, Chazeau A, Cloin BMC, Lambers MLA, Hoogenraad CC, Kapitein LC. Differentiation between oppositely oriented microtubules controls polarized neuronal transport. Neuron. 2017;96:1264\u201371.e5.","journal-title":"Neuron"},{"key":"1978_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105084","volume":"299","author":"Y Suber","year":"2023","unstructured":"Suber Y, Alam MNA, Nakos K, Bhakt P, Spiliotis ET. Microtubule-associated septin complexes modulate kinesin and dynein motility with differential specificities. J Biol Chem. 2023;299:105084.","journal-title":"J Biol Chem"},{"key":"1978_CR54","doi-asserted-by":"publisher","unstructured":"Byrd DT, Pearlman JM, Jin Y. Intragenic suppressors of unc-104 (e1265) identify potential roles of the conserved stalk region. MicroPubl Biol. 2022;2022. https:\/\/doi.org\/10.17912\/micropub.biology.000539","DOI":"10.17912\/micropub.biology.000539"},{"key":"1978_CR55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2311936121","volume":"121","author":"Y Chai","year":"2024","unstructured":"Chai Y, Li D, Gong W, Ke J, Tian D, Chen Z, et al. A plant flavonol and genetic suppressors rescue a pathogenic mutation associated with kinesin in neurons. Proc Natl Acad Sci USA. 2024;121:e2311936121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1978_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1828223","volume":"2022","author":"P He","year":"2022","unstructured":"He P, Liang J, Zhang W, Lin S, Wu H, Li Q, et al. Hematopoietic stem cell transplantation for acute myeloid leukemia: an overview of systematic reviews. Int J Clin Pract. 2022;2022:1828223.","journal-title":"Int J Clin Pract"},{"key":"1978_CR57","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/sctm.18-0154","volume":"8","author":"L Mazzini","year":"2019","unstructured":"Mazzini L, Gelati M, Profico DC, Sorar\u00f9 G, Ferrari D, Copetti M, et al. Results from phase I clinical trial with intraspinal injection of neural stem cells in amyotrophic lateral sclerosis: a long-term outcome. Stem Cells Transl Med. 2019;8:887\u201397.","journal-title":"Stem Cells Transl Med"},{"key":"1978_CR58","first-page":"611","volume":"90","author":"ME McClements","year":"2017","unstructured":"McClements ME, MacLaren RE. Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes. Yale J Biol Med. 2017;90:611\u201323.","journal-title":"Yale J Biol Med"},{"key":"1978_CR59","unstructured":"Taysha Gene Therapies I. 2024. Available from: https:\/\/ir.tayshagtx.com\/news-releases\/news-release-details\/taysha-gene-therapies-announces-positive-clinical-data-across\/"},{"key":"1978_CR60","doi-asserted-by":"crossref","unstructured":"Ingusci S, Verlengia G, Soukupova M, Zucchini S, Simonato M. Gene therapy tools for brain diseases. Front Pharmacol. 2019;10:724.","DOI":"10.3389\/fphar.2019.00724"},{"key":"1978_CR61","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/genes12060797","volume":"12","author":"M Mushtaq","year":"2021","unstructured":"Mushtaq M, Ahmad Dar A, Skalicky M, Tyagi A, Bhagat N, Basu U, et al. CRISPR-based genome editing tools: insights into technological breakthroughs and future challenges. Genes. 2021;12:797.","journal-title":"Genes"},{"key":"1978_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122685","volume":"348","author":"T Mohammadian Gol","year":"2024","unstructured":"Mohammadian Gol T, Zahedipour F, Trosien P, Ure\u00f1a-Bail\u00e9n G, Kim M, Antony JS, et al. Gene therapy in pediatrics \u2013 Clinical studies and approved drugs (as of 2023). Life Sci. 2024;348:122685.","journal-title":"Life Sci"},{"key":"1978_CR63","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/j.ymthe.2022.05.014","volume":"30","author":"BL Davidson","year":"2022","unstructured":"Davidson BL, Gao G, Berry-Kravis E, Bradbury AM, B\u00f6nnemann C, Buxbaum JD, et al. Gene-based therapeutics for rare genetic neurodevelopmental psychiatric disorders. Mol Ther. 2022;30:2416\u201328.","journal-title":"Mol Ther"},{"key":"1978_CR64","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/bioinformatics\/btv362","volume":"31","author":"W Liu","year":"2015","unstructured":"Liu W, Xie Y, Ma J, Luo X, Nie P, Zuo Z, et al. IBS: an illustrator for the presentation and visualization of biological sequences. Bioinformatics. 2015;31:3359\u201361.","journal-title":"Bioinformatics"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01978-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01978-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:02:15Z","timestamp":1791061335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01978-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1978"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01978-8","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}